Uncategorized
European Commission grants marketing authorisation to Valneva's…
June 24 (Reuters) – French drugmaker Valneva’s COVID-19 vaccine has received marketing authorisation from the European Commission (EC) for use as a primary vaccination in people from 18 to 50 years of age, the company said on Friday. The marketing authorisation will cover the European Union’s member states as well Read more…